Health Care Archives - Page 19 of 478

2 minute read

Gilead’s Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch

May 20, 9:36 AM

Gilead Sciences reports interim results from the ASSURE study of seladelpar in primary biliary cholangitis, showing significant improvements in cholestasis markers and pruritus.

GILD

2 minute read

Genetic Profile Key To Novo Nordisk’s Wegovy’s Weight-Loss Effectiveness, Study Reveals

By Vandana Singh

May 20, 9:34 AM

Certain genes may predict strong responses to Novo Nordisk's Wegovy (semaglutide) in obesity treatment, with patients showing significant weight loss linked to a "hungry gut" genetic profile. This finding could enhance personalized obesity care, optimizing treatment outcomes.

NVO

2 minute read

Oracle’s $28B Gamble On Cerner’s AI-Driven Health Records System Backfires

By Benzinga Neuro

May 20, 6:35 AM

Oracle Corporation made a $28 billion bet on Cerner Corporation to revolutionize healthcare. However, the electronic health records system has been linked to patient deaths, leading to a massive liability for Oracle.

ORCL

1 minute read

Dyne Therapeutics Announced Clinical Data From Its Ongoing Phase 1/2 ACHIEVE Trial Of DYNE-101 In Myotonic Dystrophy Type 1 And Phase 1/2 DELIVER Trial Of DYNE-251 In Duchenne Muscular Dystrophy

By Benzinga Newsdesk

May 20, 6:33 AM

In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months DYNE-101 Showed Improvement in Myotonia, Muscle Strength, and Timed

DYN

2 minute read

AbbVie Is ‘Successfully Positioned To Absorb Humira Biosimilar Erosion’: Analyst

By Vandana Singh

May 17, 1:47 PM

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.

ABBV

2 minute read

Fresenius SE’s Future With Dialysis Company Unclear, Investors Seek Answers

By Vandana Singh

May 17, 1:13 PM

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and nursing shortages impact both companies' performance and share value.

BAX

2 minute read

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

By Vandana Singh

May 17, 12:46 PM

Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.

BNTX

2 minute read

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

By Vandana Singh

May 17, 11:02 AM

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

ALPMF